Efficacy and Safety of Renal Sympathetic Denervation on Dogs with Pressure Overload-Induced Heart Failure
Copyright © 2016 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved..
BACKGROUND: In dogs with heart failure (HF) induced by overload pressure, the role of renal sympathetic denervation (RSD) on heart failure and in the renal artery is unclear. Therefore, we investigated the efficacy and safety of RSD in dogs with pressure overload-induced heart failure.
METHODS: Twenty mongrel dogs were divided into a sham-operated group, an HF group and an HF + RSD group. In the sham-operated group, the abdominal aorta was located but was not constricted, in the HF group, the abdominal aorta was constricted without RSD, and the HF+RSD group underwent RSD with constriction of the abdominal aorta after 10 weeks. Blood sampling assays, echocardiography, intravascular ultrasound (IVUS) measurement and histopathological examination were performed.
RESULTS: Renal sympathetic denervation caused a significant reduction in the levels of noradrenaline (166.62±6.84 vs. 183.48±13.66 pg/ml, P<0.05), plasma renin activity (1.93±0.12 vs. 2.10±0.13 ng/mlh, P<0.05) and B-type natriuretic peptide (71.14±3.86 vs. 83.15±5.73 pg/ml, P<0.05) at eight weeks after RSD in the HF+RSD group. Compared with the HF group at eight weeks, the left ventricular internal dimension at end-diastole and end-systole were lower and the left ventricular ejection fraction was higher (all P<0.05) at eight weeks after RSD in the HF+RSD group. Intravenous ultrasound images showed no changes in the renal artery lumen, and intimal hyperplasia and vascular lumen stenosis were not observed after RSD.
CONCLUSIONS: Renal sympathetic denervation could improve cardiac function in dogs with HF induced by pressure overload; RSD had no adverse influence on the renal artery.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
---|---|
Enthalten in: |
Heart, lung & circulation - 26(2017), 2 vom: 12. Feb., Seite 194-200 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chen, Pingan [VerfasserIn] |
---|
Links: |
---|
Themen: |
Heart failure |
---|
Anmerkungen: |
Date Completed 28.04.2017 Date Revised 28.04.2017 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.hlc.2016.06.1208 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM263700917 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM263700917 | ||
003 | DE-627 | ||
005 | 20231224204456.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.hlc.2016.06.1208 |2 doi | |
028 | 5 | 2 | |a pubmed24n0879.xml |
035 | |a (DE-627)NLM263700917 | ||
035 | |a (NLM)27555054 | ||
035 | |a (PII)S1443-9506(16)31510-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Chen, Pingan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Efficacy and Safety of Renal Sympathetic Denervation on Dogs with Pressure Overload-Induced Heart Failure |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.04.2017 | ||
500 | |a Date Revised 28.04.2017 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2016 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved. | ||
520 | |a BACKGROUND: In dogs with heart failure (HF) induced by overload pressure, the role of renal sympathetic denervation (RSD) on heart failure and in the renal artery is unclear. Therefore, we investigated the efficacy and safety of RSD in dogs with pressure overload-induced heart failure | ||
520 | |a METHODS: Twenty mongrel dogs were divided into a sham-operated group, an HF group and an HF + RSD group. In the sham-operated group, the abdominal aorta was located but was not constricted, in the HF group, the abdominal aorta was constricted without RSD, and the HF+RSD group underwent RSD with constriction of the abdominal aorta after 10 weeks. Blood sampling assays, echocardiography, intravascular ultrasound (IVUS) measurement and histopathological examination were performed | ||
520 | |a RESULTS: Renal sympathetic denervation caused a significant reduction in the levels of noradrenaline (166.62±6.84 vs. 183.48±13.66 pg/ml, P<0.05), plasma renin activity (1.93±0.12 vs. 2.10±0.13 ng/mlh, P<0.05) and B-type natriuretic peptide (71.14±3.86 vs. 83.15±5.73 pg/ml, P<0.05) at eight weeks after RSD in the HF+RSD group. Compared with the HF group at eight weeks, the left ventricular internal dimension at end-diastole and end-systole were lower and the left ventricular ejection fraction was higher (all P<0.05) at eight weeks after RSD in the HF+RSD group. Intravenous ultrasound images showed no changes in the renal artery lumen, and intimal hyperplasia and vascular lumen stenosis were not observed after RSD | ||
520 | |a CONCLUSIONS: Renal sympathetic denervation could improve cardiac function in dogs with HF induced by pressure overload; RSD had no adverse influence on the renal artery | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Heart failure | |
650 | 4 | |a Pressure overload | |
650 | 4 | |a Renal sympathetic denervation | |
650 | 7 | |a Norepinephrine |2 NLM | |
650 | 7 | |a X4W3ENH1CV |2 NLM | |
700 | 1 | |a Leng, Shuilong |e verfasserin |4 aut | |
700 | 1 | |a Luo, Yishan |e verfasserin |4 aut | |
700 | 1 | |a Li, Shaonan |e verfasserin |4 aut | |
700 | 1 | |a Huang, Zicheng |e verfasserin |4 aut | |
700 | 1 | |a Liu, Zhenxi |e verfasserin |4 aut | |
700 | 1 | |a Liu, Zhen |e verfasserin |4 aut | |
700 | 1 | |a Wang, Jie |e verfasserin |4 aut | |
700 | 1 | |a Lei, Xiaoming |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Heart, lung & circulation |d 2000 |g 26(2017), 2 vom: 12. Feb., Seite 194-200 |w (DE-627)NLM159538165 |x 1444-2892 |7 nnns |
773 | 1 | 8 | |g volume:26 |g year:2017 |g number:2 |g day:12 |g month:02 |g pages:194-200 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.hlc.2016.06.1208 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 26 |j 2017 |e 2 |b 12 |c 02 |h 194-200 |